KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Intangibles (2019 - 2025)

Historic Intangibles for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $142.1 million.

  • GoodRx Holdings' Intangibles rose 1853.24% to $142.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.1 million, marking a year-over-year increase of 1853.24%. This contributed to the annual value of $124.8 million for FY2024, which is 3074.42% up from last year.
  • GoodRx Holdings' Intangibles amounted to $142.1 million in Q3 2025, which was up 1853.24% from $138.3 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Intangibles registered a high of $157.1 million during Q4 2021, and its lowest value of $34.4 million during Q1 2021.
  • Over the past 5 years, GoodRx Holdings' median Intangibles value was $114.3 million (recorded in 2023), while the average stood at $111.9 million.
  • Per our database at Business Quant, GoodRx Holdings' Intangibles skyrocketed by 14965.89% in 2022 and then plummeted by 2694.28% in 2023.
  • Over the past 5 years, GoodRx Holdings' Intangibles (Quarter) stood at $157.1 million in 2021, then dropped by 23.71% to $119.9 million in 2022, then decreased by 20.38% to $95.4 million in 2023, then surged by 30.74% to $124.8 million in 2024, then rose by 13.89% to $142.1 million in 2025.
  • Its last three reported values are $142.1 million in Q3 2025, $138.3 million for Q2 2025, and $130.6 million during Q1 2025.